Design, Assess and Optimize for Clinical Success
We offer an entire line of in silico and in vitro services for manufacturability, immunogenicity, humanisation, and macromolecule engineering. These technologies embrace our award winning and proprietary Epibase® T cell epitope screening platform for immunogenicity assessment beside our proprietary technology platform for structural macromolecule engineering. Our Cambridge, UK-based Applied macromolecule Services scientists can assist you confirm a testing strategy, analyze and interpret the information, and suggest next steps throughout the method.
In addition to our macromolecule style and optimisation services, we have a tendency to conjointly supply a macromolecule production service for mg to kilogram quantities of each non-GMP and cGMP material. Lonza’s lightweight Path™ programs ar efficient and bottom scope development and producing services accessible for each class and microorganism applications.
Lonza’s macromolecule style and optimisation services were developed to mitigate risks, scale back attrition, and improve the standard and safety of therapeutic proteins. They conjointly address the challenges and accelerate the look and development of efficacious vaccines. These services offer an entire portfolio for your late discovery and early development wants